Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia-Reference-Cited by-同舟云学术

Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia

Published:2014-10-17 Issue:4 Volume:29 Page:828-838
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Sandhöfer N,Metzeler K H,Rothenberg M,Herold T,Tiedt S,Groiß V,Carlet M,Walter G,Hinrichsen T,Wachter O,Grunert M,Schneider S,Subklewe M,Dufour A,Fröhling S,Klein H-G,Hiddemann W,Jeremias I,Spiekermann K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014305.pdf

Reference60 articles.

1. Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H . The molecular pathogenesis of acute myeloid leukemia. Crit Rev Oncol/Hematol 2005; 56: 195–221.

2. Grandage VL, Gale RE, Linch DC, Khwaja A . PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia 2005; 19: 586–594.

3. Min YH, Eom JI, Cheong JW, Maeng HO, Kim JY, Jeung HK et al. Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable. Leukemia 2003; 17: 995–997.

4. Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, Andreeff M et al. Functional proteomic profiling of AML predicts response and survival. Blood 2009; 113: 154–164.

5. Min YH, Cheong JW, Kim JY, Eom JI, Lee ST, Hahn JS et al. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia. Cancer Res 2004; 64: 5225–5231.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma;Cancer Immunology, Immunotherapy;2024-04-17

2. Calycosin Induces Ferroptosis by SLC7A11 Through the PI3K/Akt Pathway in Acute Myelocytic Leukemia;Revista Brasileira de Farmacognosia;2024-03-04

3. Efficacy of Rotundic Acid and Its Derivatives as Promising Natural Anticancer Triterpenoids: A Literature‐Based Study;Chemistry & Biodiversity;2024-02

4. Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology;Frontiers in Immunology;2023-11-15

5. PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities;Cancers;2023-11-05